Trust Company Has Cut By $517,248 Its Abbvie (ABBV) Position; EQUITABLE GROUP ORDINARY SHARES CAN (EQGPF) Shorts Up By 8.8%

April 17, 2018 - By Dolores Ford

AbbVie Inc. (NYSE:ABBV) Logo

Trust Company decreased Abbvie Inc (ABBV) stake by 9.66% reported in 2017Q4 SEC filing. Trust Company sold 5,388 shares as Abbvie Inc (ABBV)’s stock declined 6.31%. The Trust Company holds 50,398 shares with $4.87M value, down from 55,786 last quarter. Abbvie Inc now has $148.96 billion valuation. The stock increased 1.38% or $1.28 during the last trading session, reaching $93.88. About 3.49 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since April 17, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

EQUITABLE GROUP INC ORDINARY SHARES CAN (OTCMKTS:EQGPF) had an increase of 8.8% in short interest. EQGPF’s SI was 1.18 million shares in April as released by FINRA. Its up 8.8% from 1.08 million shares previously. With 400 avg volume, 2949 days are for EQUITABLE GROUP INC ORDINARY SHARES CAN (OTCMKTS:EQGPF)’s short sellers to cover EQGPF’s short positions. The SI to EQUITABLE GROUP INC ORDINARY SHARES CAN’s float is 9.03%. It closed at $42.2688 lastly. It is down 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Since October 30, 2017, it had 0 insider purchases, and 12 insider sales for $49.35 million activity. Schumacher Laura J sold 25,000 shares worth $2.95 million. $2.15 million worth of AbbVie Inc. (NYSE:ABBV) was sold by RICHMOND TIMOTHY J.. Michael Robert A. had sold 992 shares worth $119,351. Another trade for 2,643 shares valued at $311,684 was made by SEVERINO MICHAEL on Wednesday, February 28. Shares for $8.31 million were sold by CHASE WILLIAM J on Wednesday, February 28. SALEKI-GERHARDT AZITA sold $157,458 worth of stock. $9.57 million worth of AbbVie Inc. (NYSE:ABBV) was sold by ALBAN CARLOS.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on April, 26 before the open. They expect $1.78 EPS, up 39.06% or $0.50 from last year’s $1.28 per share. ABBV’s profit will be $2.82B for 13.19 P/E if the $1.78 EPS becomes a reality. After $1.48 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 20.27% EPS growth.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.05, from 0.85 in 2017Q3. It turned negative, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. Mirador Partners LP holds 19,581 shares. Japan-based Tokio Marine Asset Management has invested 0.13% in AbbVie Inc. (NYSE:ABBV). 10,300 are owned by Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Mgmt Corporation. Outfitter Advsr Ltd owns 5,001 shares for 0.16% of their portfolio. Citigroup holds 943,011 shares. Two Sigma Securities Limited Com reported 4,316 shares. Cetera Ltd Liability reported 0.25% stake. Bainco Invsts reported 120,163 shares stake. Fort Point Ptnrs Llc holds 116,444 shares. Focused Wealth Management holds 0.04% or 1,412 shares. Moreover, Patten And Patten Incorporated Tn has 1.78% invested in AbbVie Inc. (NYSE:ABBV). Origin Asset Mgmt Llp holds 0.79% or 143,300 shares. State Farm Mutual Automobile holds 1.83% in AbbVie Inc. (NYSE:ABBV) or 15.06M shares. Connecticut-based Armstrong Shaw Assocs Ct has invested 3.59% in AbbVie Inc. (NYSE:ABBV). Picton Mahoney Asset owns 131,300 shares or 0.34% of their US portfolio.

AbbVie Inc. (NYSE:ABBV) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Dolores Ford

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: